Loss of protooncogene c-Myc function impedes G1 phase progression both before and after the restriction point

Mol Biol Cell. 2003 Mar;14(3):823-35. doi: 10.1091/mbc.e02-10-0649.

Abstract

c-myc is an important protooncogene whose misregulation is believed to causally affect the development of numerous human cancers. c-myc null rat fibroblasts are viable but display a severe (two- to threefold) retardation of proliferation. The rates of RNA and protein synthesis are reduced by approximately the same factor, whereas cell size remains unaffected. We have performed a detailed kinetic cell cycle analysis of c-myc(-/-) cells by using several labeling and synchronization methods. The majority of cells (>90%) in asynchronous, exponential phase c-myc(-/-) cultures cycle continuously with uniformly elongated cell cycles. Cell cycle elongation is due to a major lengthening of G(1) phase (four- to fivefold) and a more limited lengthening of G(2) phase (twofold), whereas S phase duration is largely unaffected. Progression from mitosis to the G1 restriction point and the subsequent progression from the restriction point into S phase are both drastically delayed. These results are best explained by a model in which c-Myc directly affects cell growth (accumulation of mass) and cell proliferation (the cell cycle machinery) by independent pathways.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antimetabolites / metabolism
  • Bromodeoxyuridine / metabolism
  • Cell Division / physiology
  • Cell Line
  • Fibroblasts / cytology
  • Fibroblasts / physiology
  • Flow Cytometry
  • G1 Phase / physiology*
  • Genes, myc*
  • Humans
  • Proto-Oncogene Proteins c-myc / genetics
  • Proto-Oncogene Proteins c-myc / metabolism*
  • RNA, Messenger / metabolism
  • Rats
  • Time Factors

Substances

  • Antimetabolites
  • Proto-Oncogene Proteins c-myc
  • RNA, Messenger
  • Bromodeoxyuridine